Semler Scientific Inc
NASDAQ:SMLR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.03
51.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SMLR stock under the Base Case scenario is 16.55 USD. Compared to the current market price of 29.97 USD, Semler Scientific Inc is Overvalued by 45%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Semler Scientific Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SMLR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Semler Scientific Inc
Balance Sheet Decomposition
Semler Scientific Inc
Current Assets | 23.7m |
Cash & Short-Term Investments | 13.4m |
Receivables | 7.5m |
Other Current Assets | 2.8m |
Non-Current Assets | 61.1m |
Long-Term Investments | 512k |
PP&E | 2.5m |
Intangibles | 54.9m |
Other Non-Current Assets | 3.1m |
Current Liabilities | 6.4m |
Accounts Payable | 227k |
Accrued Liabilities | 5.2m |
Other Current Liabilities | 959k |
Non-Current Liabilities | 24k |
Other Non-Current Liabilities | 24k |
Earnings Waterfall
Semler Scientific Inc
Revenue
|
61.7m
USD
|
Cost of Revenue
|
-7m
USD
|
Gross Profit
|
54.7m
USD
|
Operating Expenses
|
-33.9m
USD
|
Operating Income
|
20.8m
USD
|
Other Expenses
|
-5m
USD
|
Net Income
|
15.8m
USD
|
Free Cash Flow Analysis
Semler Scientific Inc
USD | |
Free Cash Flow | USD |
In Q2 2024, Semler Scientific's revenue dropped by 22% to $14.5 million. The company continues to promote its QuantaFlo product for diagnosing peripheral arterial disease but is also shifting its treasury strategy to focus on Bitcoin. They now hold 929 Bitcoins and plan to use cash flow and equity to buy more. Operating expenses decreased by 20% to $9.1 million, and net income turned flat from $5.9 million a year prior. The company's strategic shift is based on Bitcoin's growing institutional acceptance and comparative value to gold.
What is Earnings Call?
SMLR Profitability Score
Profitability Due Diligence
Semler Scientific Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
Semler Scientific Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
SMLR Solvency Score
Solvency Due Diligence
Semler Scientific Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Semler Scientific Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SMLR Price Targets Summary
Semler Scientific Inc
According to Wall Street analysts, the average 1-year price target for SMLR is 40.8 USD with a low forecast of 40.4 USD and a high forecast of 42 USD.
Dividends
Current shareholder yield for SMLR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SMLR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 124 full-time employees. The company went IPO on 2014-02-27. The firm develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. The company also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The firm's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.
Contact
IPO
Employees
Officers
The intrinsic value of one SMLR stock under the Base Case scenario is 16.55 USD.
Compared to the current market price of 29.97 USD, Semler Scientific Inc is Overvalued by 45%.